Save the date: Oct 31 to Nov 1, 2023.

Designed by famed technology futurist, George Gilder, COSM will feature an astounding array of speakers — from Amazon and Microsoft, Intel and Madrona Ventures, with keynotes and interviews with Andy Kessler, Ray Kurzweil, Stephen Wolfram, and Bob Metcalfe. Kyle Bass will expound on China, and, of course, Kyoto Prize winner Carver Mead will crown our proceedings. With special guest Stephen Balaban, founder of the meteoric new distributed AI unicorn, Lambda Labs, we promise you a COSMic vision of the luminous future of new technology.

Cathie Wood

_{CEO, Ark Invest}_{Editor
August 30, 2023}

…

Ray Kurzweil

_{Author, Inventor, Futurist}_{Editor
August 15, 2023
2}

Ray Kurzweil has been described as “the restless genius” by The Wall Street Journal, and “the ultimate thinking machine” by Forbes. Inc. magazine ranked him #8 among entrepreneurs in the United States, calling him the “rightful heir to Thomas Edison,” and PBS selected Ray as one of 16 “revolutionaries who made America,” along with other inventors of the past two centuries. He is considered one of the world’s leading inventors, thinkers, and futurists, with a 30-year track record of accurate predictions. Kurzweil was the principal inventor of the first CCD flatbed scanner, the first omni-font optical character recognition, the first print-to-speech reading machine for the blind, the first text-to-speech synthesizer, the first music synthesizer …

Stephen Wolfram

_{Founder and CEO, Wolfram Research}_{Editor
July 28, 2023}

…

Jack Selby

_{Managing Partner, AZ-VC}_{Editor
July 28, 2023}

…

Archana Vemulapalli

_{Head of Product Management and Global Strategy for Data, Analytics and AI & ML at AWS}_{Editor
July 27, 2023}

…

Vered Caplan

_{CEO, Orgenesis}_{Editor
July 13, 2023
2}

Vered Caplan is the CEO of Orgenesis Inc, a global biotech company working to unlock the full potential of cell and gene therapies in an affordable and accessible format at the point of care. Orgenesis identifies promising new therapies and leverages its POCare Platform to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production. Prior to Orgenesis, Vered has been CEO of Kamedis, a company focused on utilizing plant extracts for dermatology purposes. From 2004 to 2007, Ms. Caplan was CEO of GammaCan, a company focused on the use of immunoglobulins for the treatment of cancer. During the previous five years, Ms. Caplan has been a director of numerous companies …

Michael Milken

_{Chairman, Milken Institute, author of Faster Cures}_{Editor
July 5, 2023
1}

Michael Milken, in full Michael Robert Milken, (born July 4, 1946, Encino, California, U.S.), American financier whose “junk-bond” operations fueled many of the corporate takeovers of the …

Andy Kessler

_{Inside View, Wall Street Journal}_{Editor
June 16, 2023
1}

Andy Kessler is the author of Inside View, a column he writes for The Wall Street Journal on technology and markets and where they intersect with culture. He won the 2019 Gerald Loeb Award for commentary. He is the author of several books including Wall Street Meat and Eat People. He used to design chips at Bell Labs before working on Wall Street for PaineWebber and Morgan Stanley and then as a founder of the hedge fund Velocity …

Michael Shellenberger

_{Author and Founder, Environmental Progress}_{Editor
June 15, 2023
1}

Michael D. Shellenberger is an American author and former public relations professional whose writing has focused on the intersection of politics, the environment, climate change and nuclear power, as well as more recently on how he believes progressivism is linked to homelessness, drug addiction and mental illness. He is a co-founder of the Breakthrough Institute and the California Peace Coalition. He is also the founder of Environmental …